140 results on '"Masoudi, Frederick A."'
Search Results
2. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
3. Implementation of a Multidimensional Strategy to Reduce Post-PCI Bleeding Risk
4. Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry
5. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
6. The National Cardiovascular Data Registry Data Quality Program 2020: JACC State-of-the-Art Review
7. The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention
8. A more complete measure of vertical integration between physicians and hospitals.
9. Heterogeneity in the Prognosis of Acute Kidney Injury Following Percutaneous Coronary Intervention
10. Design of DISCOVER-HCM: A Registry of Real-world Treatment Patterns and Outcomes of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy
11. Impact of the Covid-19 Pandemic on Same-Day Discharge Adoption Following Percutaneous Coronary Intervention for Stable Cad: A National Time Series Analysis
12. Sex Differences in Characteristics, Treatments, and Outcomes Among Patients Hospitalized for Non–ST-Segment–Elevation Myocardial Infarction in China: 2006 to 2015
13. 2328. COVID-19 and CLABSI: Riding the Pandemic Waves with an Active Infection Prevention Intervention
14. Clinical Phenotyping with an Outcomes-driven Mixture of Experts for Patient Matching and Risk Estimation
15. Quality of Cardiovascular Registries: Turning the Mirror Around
16. Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning
17. Heterogeneity in the Prognosis of Acute Kidney Injury Following Percutaneous Coronary Intervention.
18. Impact of the COVID-19 Pandemic on Same-day Discharge Adoption Following Percutaneous Coronary Intervention for Stable CAD: A National Time Series Analysis
19. Trends in Short‐, Intermediate‐, and Long‐Term Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018
20. Effect of the New Glomerular Filtration Rate Estimation Equation on Risk Predicting Models for Acute Kidney Injury After Percutaneous Coronary Intervention
21. Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures
22. PROCEDURE VOLUME AND OUTCOMES WITH WATCHMAN LEFT ATRIAL APPENDAGE CLOSURE: A REPORT FROM THE NCDR LAAO REGISTRY
23. Trends in Short-, Intermediate-, and LongTerm Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018.
24. Hospital Variation of Spironolactone Use in Patients Hospitalized for Heart Failure in China—The China PEACE Retrospective Heart Failure Study
25. Comparison of Severe Maternal Morbidities Associated With Delivery During Periods of Circulation of Specific SARS-CoV-2 Variants
26. Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry
27. Effect of Text Message Reminders and Vaccine Reservations on Adherence to a Health System COVID-19 Vaccination Policy
28. Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross‐Sectional Analysis From NCDR PINNACLE Registry
29. Sex-Specific Risk Factors Associated With First Acute Myocardial Infarction in Young Adults
30. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry
31. PO-669-03 MACHINE LEARNING BASED ONE-YEAR MORTALITY PREDICTION IN PATIENTS UNDERGOING PRIMARY PREVENTION CARDIOVERTER DEFIBRILLATOR IMPLANTATION: A RETROSPECTIVE COHORT STUDY
32. Abstract 161: Trends In Time-Incremental Mortality After Hospitalization For Incident Acute Myocardial Infarction Among Medicare Beneficiaries, 2008-2017
33. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials
34. A-24 | Association of COVD-19 Pandemic with Percutaneous Coronary Interventions for ST Elevation Myocardial Infarction within a Large National Healthcare System
35. Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States
36. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018
37. Impact of COVID-19 pandemic on hospital onset bloodstream infections (HOBSI) at a large health system
38. Hospital Characteristics and Early Enrollment Trends in the American College of Cardiology Voluntary Public Reporting Program
39. Effect of removing race correction factor in glomerular filtration rate estimation on predicting acute kidney injury after percutaneous coronary intervention
40. A dynamic model to estimate evolving risk of major bleeding after percutaneous coronary intervention
41. Abstract 10210: Automating Risk Assessment of Acute Kidney Injury for Patients Undergoing Percutaneous Coronary Intervention
42. Development and piloting of four decision aids for implantable cardioverter‐defibrillators in different media formats
43. Hospital Variation of Spironolactone Use in Patients Hospitalized for Heart Failure in China-The China PEACE Retrospective Heart Failure Study.
44. Trends in Mortality After Incident Hospitalization for Heart Failure Among Medicare Beneficiaries.
45. Changes in ST segment elevation myocardial infarction hospitalisations in China from 2011 to 2015
46. Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning.
47. Changes in ST segment elevation myocardial infarzzction hospitalisations in China from 2011 to 2015.
48. PERIPROCEDURAL PERICARDIAL EFFUSION COMPLICATING TRANSCATHETER LEFT ATRIAL APPENDAGE OCCLUSION: A REPORT FROM THE NCDR LAAO REGISTRY
49. National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020.
50. FINANCIAL ANALYSIS OF SITE-LEVEL CLINICAL TRIAL PERFORMANCE.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.